查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298345

腸道疾病檢測市場：按產品類型、按技術、按疾病類型、按最終用戶：2023-2032 年全球機會分析和行業預測

Enteric Disease Testing Market By Product Type, By Technique, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 474 Pages | 商品交期: 2-3個工作天內

價格

2022年腸道疾病檢測市場價值為38.706億美元，預計到2032年將達到53.236億美元，2023年至2032年的複合年增長率為3.3%。

腸病是由影響胃腸道（也稱為腸道或消化系統）的各種微生物（包括細菌、病毒和寄生蟲）引起的感染。這些疾病通常通過受污染的食物和水、不衛生的環境和不良的衛生習慣傳播。使用分子診斷技術和免疫診斷技術來測試腸道疾病。腸道疾病檢測對於治療和預防傳染病的傳播非常重要。檢測腸道疾病需要使用各種試劑、耗材和設備。

推動腸道疾病檢測市場增長的關鍵因素包括腸道疾病檢測試劑和儀器的技術進步、新興國家政府為減輕傳染性腸病和消化性潰瘍病負擔而採取的越來越多的舉措。大腸桿菌感染、阿米巴病、賈第鞭毛蟲病、幽門螺桿菌感染、志賀氏菌和沙門氏菌感染等疾病。例如，根據美國疾病控制與預防中心 (CDC) 2023 的數據，彎曲桿菌感染每年影響 150 萬美國居民。

然而，設備的高成本以及與分子診斷測定相關的高成本預計將阻礙腸道疾病檢測市場的增長。相反，新興經濟體未滿足的醫療需求和新興經濟體利潤豐厚的商機預計將為腸道疾病檢測產品製造商創造巨大的未來機會。

此外，由於研發活動中腸道疾病檢測的使用增加、腸道疾病檢測試劑盒的高需求以及腸道疾病的高發病率，醫療保健業務預計將出現增長。此外，有效腸道疾病檢測試劑盒和設備的不斷發現和開發，以及腸道疾病診斷意識的不斷提高，正在推動印度和中國等新興國家腸道疾病檢測市場的增長。預計這將為主要參與者在預測期內投資市場提供利潤豐厚的機會。

腸道疾病檢測市場分為產品類型、技術、疾病類型、最終用戶和地區。按產品類型劃分，市場分為試劑和消耗品以及儀器。按方法劃分，市場分為分子診斷和免疫診斷。按疾病類型分為細菌性腸病、病毒性腸病、寄生蟲性腸病。按最終用戶劃分，可分為醫院實驗室、製藥和生物技術公司以及學術和研究機構。

目錄

第 1 章 簡介

第二章執行摘要

第三章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭強度
  • 市場動態
    • 促進者
      • 腸道疾病患病率上升
      • 新興國家尚未開發的市場
    • 阻礙因素
      • 分子診斷測定相關的高成本
    • 機會
      • 大公司更多地採用發展戰略
  • COVID-19 市場影響分析

4 腸道疾病檢測市場，按產品類型

  • 概述
    • 市場規模及預測
  • 試劑和耗材
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類
  • 設備
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類

5 腸道疾病檢測市場（按技術）

  • 概述
    • 市場規模及預測
  • 分子診斷
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類
  • 免疫診斷
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類

6 腸道疾病檢測市場（按疾病類型）

  • 概述
    • 市場規模和預測
  • 細菌性腸病
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類
  • 病毒性腸病
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類
  • 寄生蟲性腸病
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家

7 腸道疾病檢測市場（按最終用戶）

  • 概述
    • 市場規模和預測
  • 醫院實驗室
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類
  • 製藥和生物技術公司
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類
  • 學術/研究機構
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場份額分析：按國家分類

8 腸道疾病檢測市場（按地區）

  • 概述
    • 市場規模/預測：按地區
  • 北美
    • 主要趨勢和機遇
    • 市場規模/預測：按產品類型
    • 市場規模/預測：按技術
    • 市場規模和預測：按疾病類型
    • 市場規模/預測：按最終用戶分類
    • 市場規模/預測：按國家
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
  • 歐洲
    • 主要趨勢和機遇
    • 市場規模/預測：按產品類型
    • 市場規模/預測：按技術
    • 市場規模和預測：按疾病類型
    • 市場規模/預測：按最終用戶分類
    • 市場規模/預測：按國家
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 歐洲其他地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
  • 亞太地區
    • 主要趨勢和機遇
    • 市場規模/預測：按產品類型
    • 市場規模/預測：按技術
    • 市場規模和預測：按疾病類型
    • 市場規模/預測：按最終用戶分類
    • 市場規模/預測：按國家
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 亞太其他地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機遇
    • 市場規模/預測：按產品類型
    • 市場規模/預測：按技術
    • 市場規模和預測：按疾病類型
    • 市場規模/預測：按最終用戶分類
    • 市場規模/預測：按國家
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類
      • 其他地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按產品類型
      • 市場規模/預測：按技術
      • 市場規模和預測：按疾病類型
      • 市場規模/預測：按最終用戶分類

第9章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10大公司產品圖
  • 比賽儀表板
  • 比賽熱圖
  • 2022 年頂級公司定位

第十章公司簡介

  • Becton Dickinson & Company
  • Biomerica, Inc.
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Diasorin S.p.A.
  • Meridian Bioscience Inc.
  • Quest Diagnostics Inc.
  • Trinity Biotech
  • Coris BioConcept
  • Abbott Laboratories
Product Code: A00205

The enteric disease testing market was valued at $3,870.60 million in 2022 and is estimated to reach $5,323.60 million by 2032, exhibiting a CAGR of 3.3% from 2023 to 2032. Enteric diseases are infections caused by various microorganisms, including bacteria, viruses, and parasites, that affect the gastrointestinal tract (also known as the enteric or digestive system). These diseases are typically spread through contaminated food or water, poor sanitation, or inadequate hygiene practices. Enteric diseases are tested using molecular diagnostics techniques and immunodiagnostic techniques. Testing for enteric diseases is important for treatment, and prevention of the spread of infectious diseases. Various reagents, consumables, and equipment are used in the testing of enteric diseases.

Enteric Disease Testing Market - IMG1

Major factors driving the growth of the enteric disease testing market include rise in technological advancement in testing reagents and equipment of enteric disease, increase in initiative taken by governments in developing countries to reduce the burden of infectious enteric diseases, peptic ulcer and surge in prevalence of enteric diseases such as E. coli infection, amoebiasis, giardiasis, H. pylori infection, shigella and salmonella infection. For instance, according to Centers for Disease Control and Prevention (CDC) 2023, campylobacter infection affects 1.5 million U.S. residents every year.

However, the high cost of equipment and high cost associated with molecular diagnostic assay are expected to hamper the enteric disease testing market growth. On the contrary, unmet medical demands in developing countries and lucrative opportunities in emerging economies are expected to create immense opportunities for enteric disease testing product manufacturers in the future.

Furthermore, the healthcare business is projected to witness growth, owing to a rise in the use of enteric disease testing for research and development activities, high demand for enteric disease testing kits, and high incidence rate of enteric diseases. In addition, rise in discovery & development of effective enteric disease testing kits & equipment and increase in awareness regarding diagnosis of enteric disease drive the growth of the enteric disease testing market in developing countries such as India and China. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.

The enteric disease testing market is segmented into product type, technique, disease type, end user, and region. On the basis of product type, the market is classified into reagents and consumables, and equipment. On the basis of technique, the market is bifurcated into molecular diagnostics, and immunodiagnostics. On the basis of disease type, the market is divided into bacterial enteric disease, viral enteric disease, and parasitic enteric disease. On the basis of end user, it is segregated into hospital laboratories, pharmaceutical and biotechnology companies, academic and research institutes.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major players profiled in the report include: Abbott Laboratories, Becton Dickinson & Company, Biomerica, Inc., Biomerieux SA, Bio-Rad Laboratories, Inc., Coris Bioconcept, Diasorin S.p.A., Meridian Bioscience, Inc, Quest Diagnostics, and Trinity Biotech.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteric disease testing market analysis from 2022 to 2032 to identify the prevailing enteric disease testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the enteric disease testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global enteric disease testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Reagents and Consumables
  • Equipment

By Technique

  • Molecular Diagnostics
  • Immunodiagnostics

By Disease Type

  • Bacterial Enteric Disease
  • Viral Enteric Disease
  • Parasitic Enteric Disease

By End User

  • Academic and Research Institutes
  • Hospital Laboratories
  • Pharmaceutical and Biotechnology Companies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

  • Biomerica, Inc.
  • Diasorin S.p.A.
  • Meridian Bioscience Inc.
  • Coris BioConcept
  • Abbott Laboratories
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Quest Diagnostics Inc.
  • Becton Dickinson & Company
  • Trinity Biotech

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of enteric diseases
      • 3.4.1.2. Untapped market in developing countries
    • 3.4.2. Restraints
      • 3.4.2.1. High cost associated with molecular diagnostic assay
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in adoption of developmental strategies by key players
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents and Consumables
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Equipment
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Molecular Diagnostics
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Immunodiagnostics
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Bacterial Enteric Disease
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Viral Enteric Disease
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Parasitic Enteric Disease
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: ENTERIC DISEASE TESTING MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Hospital Laboratories
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Pharmaceutical and Biotechnology Companies
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Academic and Research Institutes
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: ENTERIC DISEASE TESTING MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Product Type
    • 8.2.3. Market size and forecast, by Technique
    • 8.2.4. Market size and forecast, by Disease Type
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Product Type
      • 8.2.6.1.3. Market size and forecast, by Technique
      • 8.2.6.1.4. Market size and forecast, by Disease Type
      • 8.2.6.1.5. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Product Type
      • 8.2.6.2.3. Market size and forecast, by Technique
      • 8.2.6.2.4. Market size and forecast, by Disease Type
      • 8.2.6.2.5. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Product Type
      • 8.2.6.3.3. Market size and forecast, by Technique
      • 8.2.6.3.4. Market size and forecast, by Disease Type
      • 8.2.6.3.5. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Product Type
    • 8.3.3. Market size and forecast, by Technique
    • 8.3.4. Market size and forecast, by Disease Type
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Product Type
      • 8.3.6.1.3. Market size and forecast, by Technique
      • 8.3.6.1.4. Market size and forecast, by Disease Type
      • 8.3.6.1.5. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Product Type
      • 8.3.6.2.3. Market size and forecast, by Technique
      • 8.3.6.2.4. Market size and forecast, by Disease Type
      • 8.3.6.2.5. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Product Type
      • 8.3.6.3.3. Market size and forecast, by Technique
      • 8.3.6.3.4. Market size and forecast, by Disease Type
      • 8.3.6.3.5. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Product Type
      • 8.3.6.4.3. Market size and forecast, by Technique
      • 8.3.6.4.4. Market size and forecast, by Disease Type
      • 8.3.6.4.5. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Product Type
      • 8.3.6.5.3. Market size and forecast, by Technique
      • 8.3.6.5.4. Market size and forecast, by Disease Type
      • 8.3.6.5.5. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Product Type
      • 8.3.6.6.3. Market size and forecast, by Technique
      • 8.3.6.6.4. Market size and forecast, by Disease Type
      • 8.3.6.6.5. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Product Type
    • 8.4.3. Market size and forecast, by Technique
    • 8.4.4. Market size and forecast, by Disease Type
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Product Type
      • 8.4.6.1.3. Market size and forecast, by Technique
      • 8.4.6.1.4. Market size and forecast, by Disease Type
      • 8.4.6.1.5. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Product Type
      • 8.4.6.2.3. Market size and forecast, by Technique
      • 8.4.6.2.4. Market size and forecast, by Disease Type
      • 8.4.6.2.5. Market size and forecast, by End User
      • 8.4.6.3. Australia
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Product Type
      • 8.4.6.3.3. Market size and forecast, by Technique
      • 8.4.6.3.4. Market size and forecast, by Disease Type
      • 8.4.6.3.5. Market size and forecast, by End User
      • 8.4.6.4. India
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Product Type
      • 8.4.6.4.3. Market size and forecast, by Technique
      • 8.4.6.4.4. Market size and forecast, by Disease Type
      • 8.4.6.4.5. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Product Type
      • 8.4.6.5.3. Market size and forecast, by Technique
      • 8.4.6.5.4. Market size and forecast, by Disease Type
      • 8.4.6.5.5. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Product Type
      • 8.4.6.6.3. Market size and forecast, by Technique
      • 8.4.6.6.4. Market size and forecast, by Disease Type
      • 8.4.6.6.5. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Product Type
    • 8.5.3. Market size and forecast, by Technique
    • 8.5.4. Market size and forecast, by Disease Type
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Product Type
      • 8.5.6.1.3. Market size and forecast, by Technique
      • 8.5.6.1.4. Market size and forecast, by Disease Type
      • 8.5.6.1.5. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Product Type
      • 8.5.6.2.3. Market size and forecast, by Technique
      • 8.5.6.2.4. Market size and forecast, by Disease Type
      • 8.5.6.2.5. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Product Type
      • 8.5.6.3.3. Market size and forecast, by Technique
      • 8.5.6.3.4. Market size and forecast, by Disease Type
      • 8.5.6.3.5. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Product Type
      • 8.5.6.4.3. Market size and forecast, by Technique
      • 8.5.6.4.4. Market size and forecast, by Disease Type
      • 8.5.6.4.5. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Becton Dickinson & Company
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
  • 10.2. Biomerica, Inc.
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
  • 10.3. Biomerieux SA
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Business performance
    • 10.3.7. Key strategic moves and developments
  • 10.4. Bio-Rad Laboratories, Inc.
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Business performance
  • 10.5. Diasorin S.p.A.
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
    • 10.5.7. Key strategic moves and developments
  • 10.6. Meridian Bioscience Inc.
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
    • 10.6.7. Key strategic moves and developments
  • 10.7. Quest Diagnostics Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
    • 10.7.7. Key strategic moves and developments
  • 10.8. Trinity Biotech
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
    • 10.8.6. Business performance
    • 10.8.7. Key strategic moves and developments
  • 10.9. Coris BioConcept
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
  • 10.10. Abbott Laboratories
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. ENTERIC DISEASE TESTING MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. ENTERIC DISEASE TESTING MARKET FOR EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 05. ENTERIC DISEASE TESTING MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. ENTERIC DISEASE TESTING MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 08. ENTERIC DISEASE TESTING MARKET FOR BACTERIAL ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. ENTERIC DISEASE TESTING MARKET FOR VIRAL ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. ENTERIC DISEASE TESTING MARKET FOR PARASITIC ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. ENTERIC DISEASE TESTING MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. ENTERIC DISEASE TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. ENTERIC DISEASE TESTING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. ENTERIC DISEASE TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 23. U.S. ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 24. U.S. ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. CANADA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. CANADA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 27. CANADA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 28. CANADA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 31. MEXICO ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 40. GERMANY ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. UK ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. UK ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 48. UK ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 49. UK ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. ITALY ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. ITALY ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 52. ITALY ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ITALY ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. SPAIN ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 59. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 61. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 64. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 65. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 66. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 67. JAPAN ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. JAPAN ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 69. JAPAN ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. CHINA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. CHINA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 73. CHINA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 74. CHINA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 76. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 77. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. INDIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 80. INDIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 81. INDIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 82. INDIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 91. LAMEA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 98. BRAZIL ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 99. BRAZIL ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 101. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 102. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 105. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 106. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 109. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 110. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 112. BECTON DICKINSON & COMPANY: KEY EXECUTIVES
  • TABLE 113. BECTON DICKINSON & COMPANY: COMPANY SNAPSHOT
  • TABLE 114. BECTON DICKINSON & COMPANY: PRODUCT SEGMENTS
  • TABLE 115. BECTON DICKINSON & COMPANY: PRODUCT PORTFOLIO
  • TABLE 116. BIOMERICA, INC.: KEY EXECUTIVES
  • TABLE 117. BIOMERICA, INC.: COMPANY SNAPSHOT
  • TABLE 118. BIOMERICA, INC.: PRODUCT SEGMENTS
  • TABLE 119. BIOMERICA, INC.: PRODUCT PORTFOLIO
  • TABLE 120. BIOMERIEUX SA: KEY EXECUTIVES
  • TABLE 121. BIOMERIEUX SA: COMPANY SNAPSHOT
  • TABLE 122. BIOMERIEUX SA: PRODUCT SEGMENTS
  • TABLE 123. BIOMERIEUX SA: PRODUCT PORTFOLIO
  • TABLE 124. BIOMERIEUX SA: KEY STRATERGIES
  • TABLE 125. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
  • TABLE 126. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • TABLE 127. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
  • TABLE 128. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
  • TABLE 129. DIASORIN S.P.A.: KEY EXECUTIVES
  • TABLE 130. DIASORIN S.P.A.: COMPANY SNAPSHOT
  • TABLE 131. DIASORIN S.P.A.: PRODUCT SEGMENTS
  • TABLE 132. DIASORIN S.P.A.: PRODUCT PORTFOLIO
  • TABLE 133. DIASORIN S.P.A.: KEY STRATERGIES
  • TABLE 134. MERIDIAN BIOSCIENCE INC.: KEY EXECUTIVES
  • TABLE 135. MERIDIAN BIOSCIENCE INC.: COMPANY SNAPSHOT
  • TABLE 136. MERIDIAN BIOSCIENCE INC.: PRODUCT SEGMENTS
  • TABLE 137. MERIDIAN BIOSCIENCE INC.: PRODUCT PORTFOLIO
  • TABLE 138. MERIDIAN BIOSCIENCE INC.: KEY STRATERGIES
  • TABLE 139. QUEST DIAGNOSTICS INC.: KEY EXECUTIVES
  • TABLE 140. QUEST DIAGNOSTICS INC.: COMPANY SNAPSHOT
  • TABLE 141. QUEST DIAGNOSTICS INC.: SERVICE SEGMENTS
  • TABLE 142. QUEST DIAGNOSTICS INC.: PRODUCT PORTFOLIO
  • TABLE 143. QUEST DIAGNOSTICS INC.: KEY STRATERGIES
  • TABLE 144. TRINITY BIOTECH: KEY EXECUTIVES
  • TABLE 145. TRINITY BIOTECH: COMPANY SNAPSHOT
  • TABLE 146. TRINITY BIOTECH: PRODUCT SEGMENTS
  • TABLE 147. TRINITY BIOTECH: PRODUCT PORTFOLIO
  • TABLE 148. TRINITY BIOTECH: KEY STRATERGIES
  • TABLE 149. CORIS BIOCONCEPT: KEY EXECUTIVES
  • TABLE 150. CORIS BIOCONCEPT: COMPANY SNAPSHOT
  • TABLE 151. CORIS BIOCONCEPT: PRODUCT SEGMENTS
  • TABLE 152. CORIS BIOCONCEPT: PRODUCT PORTFOLIO
  • TABLE 153. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 154. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 155. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 156. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. ENTERIC DISEASE TESTING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ENTERIC DISEASE TESTING MARKET, 2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN ENTERIC DISEASE TESTING MARKET (2023-2032)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALENTERIC DISEASE TESTING MARKET
  • FIGURE 10. ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR EQUIPMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR BACTERIAL ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR VIRAL ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR PARASITIC ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. ENTERIC DISEASE TESTING MARKET, BY END USER, 2022(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. ENTERIC DISEASE TESTING MARKET BY REGION, 2022
  • FIGURE 25. U.S. ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. CANADA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. MEXICO ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. GERMANY ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. FRANCE ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. UK ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. ITALY ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SPAIN ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. JAPAN ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. CHINA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. BRAZIL ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 48. COMPETITIVE DASHBOARD
  • FIGURE 49. COMPETITIVE HEATMAP: ENTERIC DISEASE TESTING MARKET
  • FIGURE 50. TOP PLAYER POSITIONING, 2022
  • FIGURE 51. BECTON DICKINSON & COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 52. BECTON DICKINSON & COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 53. BECTON DICKINSON & COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. BECTON DICKINSON & COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. BIOMERICA, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 56. BIOMERICA, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
  • FIGURE 57. BIOMERICA, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 58. BIOMERIEUX SA: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 59. BIOMERIEUX SA: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 60. BIOMERIEUX SA: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 61. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. DIASORIN S.P.A.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 65. DIASORIN S.P.A.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 66. MERIDIAN BIOSCIENCE INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 67. MERIDIAN BIOSCIENCE INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
  • FIGURE 68. MERIDIAN BIOSCIENCE INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 69. MERIDIAN BIOSCIENCE INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 70. QUEST DIAGNOSTICS INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 71. QUEST DIAGNOSTICS INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 72. TRINITY BIOTECH: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 73. TRINITY BIOTECH: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 74. TRINITY BIOTECH: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 75. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 76. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 77. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)